Neglected Tropical Diseases Diagnosis Market Size, Share, Trends, Growth Outlook

Neglected Tropical Diseases Diagnosis Market is estimated to increase at a growth rate of 4.9% CAGR over the forecast period from 2024 to 2030.

The global Neglected Tropical Diseases Diagnosis Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Disease (Dengue, Chikungunya, Rabies, Leprosy, Buruli ulcer, Yaws, Lymphatic Filariasis, Taeniasis/Cysticercosis, Foodborne trematode infections, Echinococcosis, Chagas disease, Dracunculiasis, Human African trypanosomiasis (sleeping sickness), Soil-transmitted helminthiases, Onchocerciasis, Schistosomiasis, Scabies, Snakebite Envenoming, Leishmaniases), By Diagnostic Method (Conventional Method, Molecular/Modern Method), By Service (Centralized Service, POC Service), By End-user (Clinical Labs, Hospitals /Clinics, Home Healthcare).

An introduction to Neglected Tropical Diseases Diagnosis Market in 2024

The Neglected Tropical Diseases (NTDs) Diagnosis market demonstrates significant growth in 2024, fueled by the increasing recognition of NTDs as a global health priority, the expansion of screening and diagnostic programs in endemic regions, and advancements in diagnostic technologies for detecting and monitoring neglected tropical infections. NTDs are a diverse group of infectious diseases that primarily affect marginalized populations in low-resource settings, including parasitic infections such as malaria, dengue fever, leishmaniasis, schistosomiasis, and soil-transmitted helminthiasis. Market dynamics are shaped by factors such as the rising incidence of NTDs due to factors such as poverty, urbanization, climate change, and globalization, the growing demand for accurate and affordable diagnostic tests in resource-limited settings, and the implementation of integrated control and elimination strategies by governments, NGOs, and international organizations. Collaboration between diagnostic companies, research institutions, and public health agencies drives innovation in the NTDs Diagnosis market, leading to the development of rapid diagnostic tests, point-of-care devices, and molecular assays that enable early detection, surveillance, and treatment monitoring of neglected tropical infections, thereby supporting disease control efforts, reducing morbidity and mortality, and promoting health equity and social justice.

Neglected Tropical Diseases Diagnosis Market Trend: Increased Focus on Point-of-Care Testing

A prominent trend in the Neglected Tropical Diseases (NTDs) Diagnosis Market is the increased focus on point-of-care testing (POCT). With the aim of improving access to timely diagnosis and treatment in resource-limited settings where NTDs are prevalent, there's a growing demand for rapid and accurate diagnostic tools that can be used at the point of care. POCT devices for NTDs offer advantages such as simplicity, portability, and rapid results, facilitating early detection and enabling prompt initiation of treatment, thus shaping the market landscape towards point-of-care solutions.

Neglected Tropical Diseases Diagnosis Market Driver: Global Health Initiatives and Funding Support

A significant driver propelling the Neglected Tropical Diseases Diagnosis Market is the support from global health initiatives and funding organizations. Initiatives such as the World Health Organization's (WHO) NTD Roadmap and partnerships like the Global Fund to Fight AIDS, Tuberculosis and Malaria prioritize the control and elimination of NTDs through enhanced surveillance, diagnosis, and treatment programs. Funding support from government agencies, philanthropic organizations, and non-profit entities drives research and development efforts, encourages innovation in diagnostic technologies, and accelerates market growth in addressing neglected tropical diseases.

Neglected Tropical Diseases Diagnosis Market Opportunity: Development of Multiplex Diagnostic Platforms

An enticing opportunity within the Neglected Tropical Diseases Diagnosis Market lies in the development of multiplex diagnostic platforms. NTDs often coexist or present with similar symptoms, requiring comprehensive diagnostic approaches to distinguish between different pathogens and diseases. Multiplex diagnostic platforms capable of simultaneously detecting multiple NTDs or pathogens in a single assay offer advantages such as increased efficiency, reduced costs, and improved diagnostic accuracy. By investing in the development of multiplex diagnostic solutions tailored for NTDs, companies can address the diagnostic challenges associated with these diseases, enhance surveillance efforts, and contribute to the control and elimination of NTDs globally, thus unlocking new opportunities for market expansion.

Neglected Tropical Diseases Diagnosis Market Market Segmentation

By Disease
Dengue
Chikungunya
Rabies
Leprosy
Buruli ulcer
Yaws
Lymphatic Filariasis
Taeniasis/Cysticercosis
Foodborne trematode infections
Echinococcosis
Chagas disease
Dracunculiasis
Human African trypanosomiasis (sleeping sickness)
Soil-transmitted helminthiases
Onchocerciasis
Schistosomiasis
Scabies
Snakebite Envenoming
Leishmaniases
By Diagnostic Method
Conventional Method
Molecular/Modern Method
By Service
Centralized Service
POC Service
By End-user
Clinical Labs
Hospitals /Clinics
Home Healthcare

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Neglected Tropical Diseases Diagnosis Market Companies

Abbott
Coris BioConcept
DiaSys Diagnostic Systems GmbH
F. Hoffmann-La Roche Ltd
Genome Diagnostics Pvt Ltd
InBios International Inc
Omega Diagnostics Group PLC
Oscar Medicare Pvt Ltd
Thermo Fisher Scientific Inc
ZeptoMetrix

Reasons to Buy the Neglected Tropical Diseases Diagnosis Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Neglected Tropical Diseases Diagnosis Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Neglected Tropical Diseases Diagnosis Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Neglected Tropical Diseases Diagnosis Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Neglected Tropical Diseases Diagnosis Market Size Outlook, $ Million, 2021 to 2030
3.2 Neglected Tropical Diseases Diagnosis Market Outlook by Type, $ Million, 2021 to 2030
3.3 Neglected Tropical Diseases Diagnosis Market Outlook by Product, $ Million, 2021 to 2030
3.4 Neglected Tropical Diseases Diagnosis Market Outlook by Application, $ Million, 2021 to 2030
3.5 Neglected Tropical Diseases Diagnosis Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Neglected Tropical Diseases Diagnosis Industry
4.2 Key Market Trends in Neglected Tropical Diseases Diagnosis Industry
4.3 Potential Opportunities in Neglected Tropical Diseases Diagnosis Industry
4.4 Key Challenges in Neglected Tropical Diseases Diagnosis Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Neglected Tropical Diseases Diagnosis Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Neglected Tropical Diseases Diagnosis Market Outlook by Segments
7.1 Neglected Tropical Diseases Diagnosis Market Outlook by Segments, $ Million, 2021- 2030
By Disease
Dengue
Chikungunya
Rabies
Leprosy
Buruli ulcer
Yaws
Lymphatic Filariasis
Taeniasis/Cysticercosis
Foodborne trematode infections
Echinococcosis
Chagas disease
Dracunculiasis
Human African trypanosomiasis (sleeping sickness)
Soil-transmitted helminthiases
Onchocerciasis
Schistosomiasis
Scabies
Snakebite Envenoming
Leishmaniases
By Diagnostic Method
Conventional Method
Molecular/Modern Method
By Service
Centralized Service
POC Service
By End-user
Clinical Labs
Hospitals /Clinics
Home Healthcare

8 North America Neglected Tropical Diseases Diagnosis Market Analysis and Outlook To 2030
8.1 Introduction to North America Neglected Tropical Diseases Diagnosis Markets in 2024
8.2 North America Neglected Tropical Diseases Diagnosis Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Neglected Tropical Diseases Diagnosis Market size Outlook by Segments, 2021-2030
By Disease
Dengue
Chikungunya
Rabies
Leprosy
Buruli ulcer
Yaws
Lymphatic Filariasis
Taeniasis/Cysticercosis
Foodborne trematode infections
Echinococcosis
Chagas disease
Dracunculiasis
Human African trypanosomiasis (sleeping sickness)
Soil-transmitted helminthiases
Onchocerciasis
Schistosomiasis
Scabies
Snakebite Envenoming
Leishmaniases
By Diagnostic Method
Conventional Method
Molecular/Modern Method
By Service
Centralized Service
POC Service
By End-user
Clinical Labs
Hospitals /Clinics
Home Healthcare

9 Europe Neglected Tropical Diseases Diagnosis Market Analysis and Outlook To 2030
9.1 Introduction to Europe Neglected Tropical Diseases Diagnosis Markets in 2024
9.2 Europe Neglected Tropical Diseases Diagnosis Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Neglected Tropical Diseases Diagnosis Market Size Outlook by Segments, 2021-2030
By Disease
Dengue
Chikungunya
Rabies
Leprosy
Buruli ulcer
Yaws
Lymphatic Filariasis
Taeniasis/Cysticercosis
Foodborne trematode infections
Echinococcosis
Chagas disease
Dracunculiasis
Human African trypanosomiasis (sleeping sickness)
Soil-transmitted helminthiases
Onchocerciasis
Schistosomiasis
Scabies
Snakebite Envenoming
Leishmaniases
By Diagnostic Method
Conventional Method
Molecular/Modern Method
By Service
Centralized Service
POC Service
By End-user
Clinical Labs
Hospitals /Clinics
Home Healthcare

10 Asia Pacific Neglected Tropical Diseases Diagnosis Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Neglected Tropical Diseases Diagnosis Markets in 2024
10.2 Asia Pacific Neglected Tropical Diseases Diagnosis Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Neglected Tropical Diseases Diagnosis Market size Outlook by Segments, 2021-2030
By Disease
Dengue
Chikungunya
Rabies
Leprosy
Buruli ulcer
Yaws
Lymphatic Filariasis
Taeniasis/Cysticercosis
Foodborne trematode infections
Echinococcosis
Chagas disease
Dracunculiasis
Human African trypanosomiasis (sleeping sickness)
Soil-transmitted helminthiases
Onchocerciasis
Schistosomiasis
Scabies
Snakebite Envenoming
Leishmaniases
By Diagnostic Method
Conventional Method
Molecular/Modern Method
By Service
Centralized Service
POC Service
By End-user
Clinical Labs
Hospitals /Clinics
Home Healthcare

11 South America Neglected Tropical Diseases Diagnosis Market Analysis and Outlook To 2030
11.1 Introduction to South America Neglected Tropical Diseases Diagnosis Markets in 2024
11.2 South America Neglected Tropical Diseases Diagnosis Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Neglected Tropical Diseases Diagnosis Market size Outlook by Segments, 2021-2030
By Disease
Dengue
Chikungunya
Rabies
Leprosy
Buruli ulcer
Yaws
Lymphatic Filariasis
Taeniasis/Cysticercosis
Foodborne trematode infections
Echinococcosis
Chagas disease
Dracunculiasis
Human African trypanosomiasis (sleeping sickness)
Soil-transmitted helminthiases
Onchocerciasis
Schistosomiasis
Scabies
Snakebite Envenoming
Leishmaniases
By Diagnostic Method
Conventional Method
Molecular/Modern Method
By Service
Centralized Service
POC Service
By End-user
Clinical Labs
Hospitals /Clinics
Home Healthcare

12 Middle East and Africa Neglected Tropical Diseases Diagnosis Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Neglected Tropical Diseases Diagnosis Markets in 2024
12.2 Middle East and Africa Neglected Tropical Diseases Diagnosis Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Neglected Tropical Diseases Diagnosis Market size Outlook by Segments, 2021-2030
By Disease
Dengue
Chikungunya
Rabies
Leprosy
Buruli ulcer
Yaws
Lymphatic Filariasis
Taeniasis/Cysticercosis
Foodborne trematode infections
Echinococcosis
Chagas disease
Dracunculiasis
Human African trypanosomiasis (sleeping sickness)
Soil-transmitted helminthiases
Onchocerciasis
Schistosomiasis
Scabies
Snakebite Envenoming
Leishmaniases
By Diagnostic Method
Conventional Method
Molecular/Modern Method
By Service
Centralized Service
POC Service
By End-user
Clinical Labs
Hospitals /Clinics
Home Healthcare

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott
Coris BioConcept
DiaSys Diagnostic Systems GmbH
F. Hoffmann-La Roche Ltd
Genome Diagnostics Pvt Ltd
InBios International Inc
Omega Diagnostics Group PLC
Oscar Medicare Pvt Ltd
Thermo Fisher Scientific Inc
ZeptoMetrix
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Disease
Dengue
Chikungunya
Rabies
Leprosy
Buruli ulcer
Yaws
Lymphatic Filariasis
Taeniasis/Cysticercosis
Foodborne trematode infections
Echinococcosis
Chagas disease
Dracunculiasis
Human African trypanosomiasis (sleeping sickness)
Soil-transmitted helminthiases
Onchocerciasis
Schistosomiasis
Scabies
Snakebite Envenoming
Leishmaniases
By Diagnostic Method
Conventional Method
Molecular/Modern Method
By Service
Centralized Service
POC Service
By End-user
Clinical Labs
Hospitals /Clinics
Home Healthcare